Latent period of 9 years in the presentation of a myeloproliferative disorder.
A woman developed a leukaemic infiltrate at the site of a smallpox vaccination; the lesion subsequently regressed spontaneously. 9 years later she developed a generalised myeloproliferative disorder.
D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000473:pathology*; D015122:Mercaptopurine / Q000627:therapeutic use; D012877:Skin Manifestations; D013997:Time Factors
D003561:Cytarabine; D015122:Mercaptopurine; D003630:Daunorubicin